CD68 and neoplasm: Over 50% of immune cells were CD68+ macrophages, predominantly CD68+HLA-DR−CD163− M0 and CD68+CD163+ M2 subtypes over the CD68+HLA-DR+ M1 subtype, suggesting a pro-tumor and immunosuppressive TME.